Poor management of hepatitis C infection will cause serious issues for patients with advanced chronic kidney disease
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of evidence-based medicine - 14(2021), 2 vom: 19. Mai, Seite 87-89 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Erken, Ertugrul [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiviral Agents |
|---|
| Anmerkungen: |
Date Completed 28.10.2021 Date Revised 28.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jebm.12433 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325402671 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325402671 | ||
| 003 | DE-627 | ||
| 005 | 20231225192349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jebm.12433 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1084.xml |
| 035 | |a (DE-627)NLM325402671 | ||
| 035 | |a (NLM)33988914 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Erken, Ertugrul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Poor management of hepatitis C infection will cause serious issues for patients with advanced chronic kidney disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.10.2021 | ||
| 500 | |a Date Revised 28.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Hepatitis C virus | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a direct acting antiviral agents | |
| 650 | 4 | |a hemodialysis | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Altunoren, Orcun |e verfasserin |4 aut | |
| 700 | 1 | |a Gungor, Ozkan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of evidence-based medicine |d 2008 |g 14(2021), 2 vom: 19. Mai, Seite 87-89 |w (DE-627)NLM206067801 |x 1756-5391 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2021 |g number:2 |g day:19 |g month:05 |g pages:87-89 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jebm.12433 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2021 |e 2 |b 19 |c 05 |h 87-89 | ||